FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lori Wirth

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
David J Sher; Lori J Wirth; Donald Annino; Tracy A Balboni; Laura A Goguen; Robert I Haddad; Charles M Norris; Marshall R Posner; Roy B Tishler
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
Robert I Haddad; Roy B Tishler; Charles Norris; Laura A Goguen; Tracy A Balboni; Rosemary Costello; Lori J Wirth; Jochen Lorch; Britta Andreozzi; Donald Annino; Marshall R Posner
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
Martin J Schlumberger; Rossella Elisei; Lars Bastholt; Lori J Wirth; Renato G Martins; Laura D Locati; Barbara Jarzab; Furio Pacini; Chantal Daumerie; Jean-Pierre Droz; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Steven I Sherman
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lori Wirth (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: David J Sher; Lori J Wirth; Donald Annino; Tracy A Balboni; Laura A Goguen; Robert I Haddad; Charles M Norris; Marshall R Posner; Roy B Tishler
Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
International journal of radiation oncology, biology, physics 2011;80(5):1405-11.
2009: Robert I Haddad; Roy B Tishler; Charles Norris; Laura A Goguen; Tracy A Balboni; Rosemary Costello; Lori J Wirth; Jochen Lorch; Britta Andreozzi; Donald Annino; Marshall R Posner
Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4448-53.
2009: Martin J Schlumberger; Rossella Elisei; Lars Bastholt; Lori J Wirth; Renato G Martins; Laura D Locati; Barbara Jarzab; Furio Pacini; Chantal Daumerie; Jean-Pierre Droz; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Steven I Sherman
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3794-801.
2009: Jochen H Lorch; Marshall R Posner; Lori J Wirth; Robert I Haddad
Seeking alternative biological therapies: the future of targeted molecular treatment.
Oral oncology 2009;45(4-5):447-53.
2008: Jochen H Lorch; Marshall R Posner; Lori J Wirth; Robert I Haddad
Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?
Hematology/oncology clinics of North America 2008;22(6):1155-63, viii.
2008: Lori J Wirth; Jeffrey F Krane; Yi Li; Megan Othus; Amy E Moran; David M Dorfman; Charles M Norris; Laura Goguen; Marshall R Posner; Robert I Haddad; Monica M Bertagnolli
A pilot surrogate endpoint biomarker study of celecoxib in oral premalignant lesions.
Cancer prevention research (Philadelphia, Pa.) 2008;1(5):339-48.
2008: Steven I Sherman; Lori J Wirth; Jean Pierre Droz; Michael Hofmann; Lars Bastholt; Renato G Martins; Lisa Licitra; Michael J Eschenberg; Yu-Nien Sun; Todd Juan; Daniel E Stepan; Martin J Schlumberger
Motesanib diphosphate in progressive differentiated thyroid cancer.
The New England journal of medicine 2008;359(1):31-42.
2008: Nathan A Pennell; Gilbert H Daniels; Robert I Haddad; Douglas S Ross; Tracey Evans; Lori J Wirth; Panos H Fidias; Jennifer S Temel; Sarada Gurubhagavatula; C. Rebecca Suk Heist; John R Clark; Thomas J Lynch
A phase II study of gefitinib in patients with advanced thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2008;18(3):317-23.
2007: Lori J Wirth; Marshall R Posner
Recent advances in combined modality therapy for locally advanced head and neck cancer.
Current cancer drug targets 2007;7(7):674-80.
2007: Rachel A Freedman; Lori J Wirth; Lucian R Chirieac; Eric C Huang
Glioblastoma in a patient with early-stage tonsil cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2848-50.
2006: Lori J Wirth; Aaron M. Allen; Mitchell Machtay
Altered fractionation: a fractional benefit?
Lancet 2006;368(9538):819-21.
2006: Robert I Haddad; Lori J Wirth; Marshall R Posner
Emerging drugs for head and neck cancer.
Expert opinion on emerging drugs 2006;11(3):461-7.
2006: Roy B Tishler; Marshall R Posner; Charles M Norris; Anand Mahadevan; Christopher Sullivan; Laura A Goguen; Lori J Wirth; Rosemary Costello; MaryAnn Case; Sara Stowell; Dan Sammartino; Paul Busse; Robert I Haddad
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
International journal of radiation oncology, biology, physics 2006;65(4):1036-44.
2006: Robert I Haddad; Roy B Tishler; Lori J Wirth; Charles M Norris; Laura A Goguen; Christopher Sullivan; Lindsay O'Donnell; Yi Li; Marshall R Posner
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
Archives of otolaryngology--head & neck surgery 2006;132(6):678-81.
2006: Laura A Goguen; Marshall R Posner; Charles M Norris; Roy B Tishler; Lori J Wirth; Donald J Annino; Adele Gagne; Christopher A Sullivan; Daniel E Sammartino; Robert I Haddad
Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2006;134(6):916-22.
2006: Laura A Goguen; Marshall R Posner; Roy B Tishler; Lori J Wirth; Charles M Norris; Donald J Annino; Christopher A Sullivan; Yi Li; Robert I Haddad
Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2006;132(5):526-31.
2006: Robert I Haddad; Marshall R Posner; Paul Busse; Charles M Norris; Laura A Goguen; Lori J Wirth; Russell A Blinder; Jeffrey F Krane; Roy B Tishler
Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach.
American journal of clinical oncology 2006;29(2):153-7.
2006: Marshall R Posner; Lori J Wirth
Cetuximab and radiotherapy for head and neck cancer.
The New England journal of medicine 2006;354(6):634-6.
2006: Robert I Haddad; Aaron Allen; Lori J Wirth; Roy B Tishler; Marshall R Posner
Integrating novel agents into the curative treatment of head and neck cancer.
Expert review of anticancer therapy 2006;6(2):157-9.
2005: Lori J Wirth; Robert I Haddad; Neal Lindeman; Xiaojun Zhao; Jeffrey C Lee; Victoria A Joshi; Charles M Norris; Marshall R Posner
Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6976-81.
2005: Beverly A Guadagnolo; Robert I Haddad; Marshall R Posner; Linda Weeks; Lori J Wirth; Charles M Norris; Christopher A Sullivan; Laura A Goguen; Paul Busse; Roy B Tishler
Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.
American journal of clinical oncology 2005;28(4):371-8.
2005: Abhay S Gokhale; Robert I Haddad; Lisa A Cavacini; Lori J Wirth; Linda Weeks; Melissa Hallar; Jarrod Faucher; Marshall R Posner
Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
Oral oncology 2005;41(1):70-6.
2004: Marshall R Posner; Robert I Haddad; Lori J Wirth; Charles M Norris; Laura A Goguen; Anand Mahadevan; Christopher Sullivan; Roy B Tishler
Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach.
Seminars in oncology 2004;31(6):778-85.
2004: Christopher A Sullivan; Michael T Jaklitsch; Robert I Haddad; Laura A Goguen; Adele Gagne; Lori J Wirth; Marshall R Posner; Roy B Tishler; Charles M Norris
Endoscopic management of hypopharyngeal stenosis after organ sparing therapy for head and neck cancer.
The Laryngoscope 2004;114(11):1924-31.
2004: Lori J Wirth; Mark R Carter; Pasi A Janne; Bruce E Johnson
Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.
Lung cancer (Amsterdam, Netherlands) 2004;44(2):213-20.
2003: Robert I Haddad; Lori J Wirth; Rosemary Costello; Linda Weeks; Marshall R Posner
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.
Seminars in oncology 2003;30(6 Suppl 18):84-8.
2003: Lori J Wirth; Robert I Haddad; Marshall R Posner
Progress and perspectives in chemoprevention of head and neck cancer.
Expert review of anticancer therapy 2003;3(3):339-55.
2003: Robert I Haddad; Lori J Wirth; Marshall R Posner
Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
Expert review of anticancer therapy 2003;3(3):331-8.
2003: Lori J Wirth; Joan Lucca; Patricia Ostler; Panos Fidias; Cathy Lynch; Pasi A Janne; Roy S Herbst; Bruce E Johnson; David J Sugarbaker; Douglas J Mathisen; Jeanne M Lukanich; Noah C Choi; Stuart M Berman; Arthur T Skarin
Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1698-704.
2003: Robert I Haddad; Roy B Tishler; Charles M Norris; Anand Mahadevan; Paul Busse; Lori J Wirth; Laura A Goguen; Christopher A Sullivan; Rosemary Costello; Mary Ann Case; Marshall R Posner
Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
The oncologist 2003;8(1):35-44.